Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Ligand acquires financial rights to portfolio of programs from Selexis

May 3, 2013

Servier to use Afraxis' ESP Technology for drug discovery

May 3, 2013

BioSavita and Quanta BioDesign enter collaboration to BioSuperior therapeutics

May 3, 2013

Forma Therapeutics and Celgene to advance drugs targeting protein homeostasis

May 2, 2013

Heptares Therapeutics achieves milestones in GPCR collaboration

May 2, 2013

New software application for personalized medicine presented

April 30, 2013

Impel NeuroPharma completes proof-of-concept study for nose-to-brain drug delivery technology

April 24, 2013

Sareum and SRI International sign codevelopment agreement for TYK2 inhibitors

April 23, 2013

Interprotein and Takeda sign new molecular design agreement

April 19, 2013

Zymeworks achieves second milestone in collaboration with Merck & Co.

April 17, 2013

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...